#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	2990	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2840	251.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1710	1710	C	343	C,A	317,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4982	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4165	287.3	0	.	n	.	0	T695C	SNP	695	695	T	1295	1295	C	332	C	300	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4982	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4165	287.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	2238	2238	G	335	G,A	230,86	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4982	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4165	287.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2571	2571	C	368	C,T	333,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4982	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4165	287.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2645	2645	A	352	A	325	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4982	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4165	287.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3197	3197	C	354	C	320	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	366	folP	855	855	100.0	folP.l6.c4.ctg.1	2109	41.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1328	1330	AGC	39;39;39	A,G;G,C;C	38,1;38,1;39	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1020	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4116	59.7	1	SNP	p	S91F	1	.	.	271	273	TTC	1001	1003	TTC	60;60;60	T;T;C,T,G	57;58;56,1,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1020	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4116	59.7	1	SNP	p	G95N	0	.	.	283	285	GGC	1013	1015	GGC	64;65;65	G;G;C	61;62;62	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1020	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4116	59.7	1	SNP	p	D95G	1	.	.	283	285	GGC	1013	1015	GGC	64;65;65	G;G;C	61;62;62	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1020	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4116	59.7	0	HET	.	.	.	C2313G	.	2313	2313	C	3043	3043	C	60	C,G	32,6	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1020	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4116	59.7	0	HET	.	.	.	T2396A,C	.	2396	2396	T	3126	3126	T	57	T,A,C	45,7,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	360	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1880	46.9	1	SNP	p	G45D	0	.	.	133	135	GGC	833	835	GGC	94;94;94	G;G;C,T	85;84;84,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	258	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1604	38.6	0	.	n	.	0	A197.	DEL	197	197	A	898	898	A	82	A	77	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3851	54.8	1	SNP	p	D86N	0	.	.	256	258	GAC	1199	1201	GAC	55;57;59	G;A;C	39;33;41	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3851	54.8	1	SNP	p	R87W	0	.	.	259	261	CGT	1202	1204	CGT	60;60;61	C;G,C;T,G	47;37,1;47,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3851	54.8	1	SNP	p	S87R	1	.	.	259	261	CGT	1202	1204	CGT	60;60;61	C;G,C;T,G	47;37,1;47,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3851	54.8	1	SNP	p	R87I	0	.	.	259	261	CGT	1202	1204	CGT	60;60;61	C;G,C;T,G	47;37,1;47,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	880	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3851	54.8	1	SNP	p	S88P	0	.	.	262	264	TCC	1205	1207	TCC	61;62;62	T;C,T;C,G	44;46,1;49,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	886	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3332	64.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1897	1899	GGC	69;70;70	G;G;C,G	60;61;61,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	634	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2771	53.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1444	1446	GCC	78;79;79	G;C,G;C	73;73,1;74	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	634	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2771	53.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1447	1449	ATG	80;82;81	A;T,A;G	75;76,1;75	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	634	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2771	53.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1459	1461	ACC	81;81;80	A,T;C,T;C	74,2;75,1;75	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	634	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2771	53.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1459	1461	ACC	81;81;80	A,T;C,T;C	74,2;75,1;75	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	634	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2771	53.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1960	1962	ACC	75;74;75	A;C,A;C	69;68,1;71	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	634	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2771	53.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2014	2016	GCG	66;65;65	G;C,G;G	59;51,1;57	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	634	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2771	53.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2014	2016	GCG	66;65;65	G;C,G;G	59;51,1;57	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	634	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2771	53.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2137	2139	GGT	53;53;51	G;G,T;T	48;47,1;47	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	634	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2771	53.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2146	2148	AGC	50;50;49	A;G;C,G	37;40;39,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	634	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2771	53.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2164	2166	CCG	42;42;42	C,G;C,G;G	33,1;33,1;33	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	764	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3865	46.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1965	1967	CCG	78;78;78	C,T,G;C,G;G,C	56,1,1;62,1;52,3	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	336	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2671	30.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	998	998	C	30	C	27	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	496	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	2283	52.5	1	SNP	p	G120K	1	.	.	358	360	AAG	879	881	AAG	75;75;75	A,C;A,C;G,A	71,1;72,1;71,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	496	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	2283	52.5	1	SNP	p	A121N	1	.	.	361	363	AAC	882	884	AAC	75;75;75	A;A;C	71;72;71	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	496	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	2283	52.5	1	SNP	p	N121D	0	.	.	361	363	AAC	882	884	AAC	75;75;75	A;A;C	71;72;71	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1522	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5453	66.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	228	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1730	32.8	1	SNP	p	V57M	1	.	.	169	171	ATG	846	848	ATG	71;71;71	A;T;G	63;67;67	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
